Clinical Trial Update: Pulmicort Respules on Relapse Rates After Treatment in the ED [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Pulmicort Respules for relapse rates after emergency department treatment in asthma was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Pulmicort Respules (budesonide)

Snippet

Sponsor: Phoenix Children's Hospital | Conditions: Asthma | Phase 4 | Status: WITHDRAWN